COVID-19:
COVID-19 public health information from the US CDC |
COVID-19 research information from the US NIH |
Español |
COVID-19 resources for global health researchers
Malaria news, resources and funding for global health researchers
Malaria is a mosquito-borne disease causing fever, chills and flu-like illness that can be fatal. Despite an increased focus on malaria, it still claims hundreds of thousands of lives each year, most of them children in Africa. Poor quality antimalarial drugs, which lead to
drug resistance and inadequate treatment, are also a growing concern, posing an urgent threat to vulnerable populations.
Fogarty has supported a wide range of efforts to combat malaria, including the
Multilateral Initiative on Malaria, an international effort to identify and address malaria research priorities.
Ecology and Evolution of Infectious Diseases, a joint NIH - National Science Foundation (NSF) initiative, funds malaria-related projects in Kenya, Papua New Guinea, Belize and more. Through the
Global Infectious Disease program, Fogarty has supported research training efforts that advance scientific discoveries, while developing local malaria research capacity in places where it's needed most.
Fogarty's
epidemiology division studies malaria transmission patterns, drug resistance and other related topics, modeling malaria's prevalence and impact.
Top News
-
NIH researchers discover new set of channels connecting malaria parasite and blood cells
Discovery provides new target for anti-malaria treatments
NICHD/NIH news, July 30, 2020 - Foundation for the NIH launches GeneConvene Global Collaborative
FNIH news, July 23, 2020 - World Malaria Day 2020: Zero malaria starts with me
NIAID Now blog, April 24, 2020 - World Malaria Day 2020: CDC and partners continue the fight against a global killer
CDC news, April 24, 2020 - Assessment of long-term health effects of antimalarial drugs when used for prophylaxis
National Academies of Sciences, Engineering and Medicine, 2020 - Profile: Fogarty Fellow Jillian Armstrong studies novel malaria detection device in Cameroon
January / February 2020
Global Health Matters -
NIH study supports new approach for treating cerebral malaria
NINDS/NIH news, February 18, 2020 -
First human trial of monoclonal antibody to prevent malaria opens
NIH trial will test NIAID-developed antibody
NIAID/NIH news, January 27, 2020 -
Malaria eradication within a generation: ambitious, achievable and necessary
Lancet Commission, September 8, 2019 -
Falsified and substandard drugs: Stopping the pandemic [Free access], co-authored by Dr Joel Breman, Fogarty senior scientific adviser emeritus
American Journal of Tropical Medicine and Hygiene, May 1, 2019 -
Poor quality drugs for treating malaria, pneumonia, hypertension and other diseases pose “public health emergency,” study says
Mar / Apr 2019
Global Health Matters -
Early stage clinical trial of antimalarial drug begins
NIAID/NIH news, September 10, 2018 -
NIH researchers identify sequence leading to release of malaria parasites from red blood cells
NICHD/NIH news, July 11, 2018 -
Tagging essential malaria genes to advance drug development
Blog post by NIH Director Dr. Francis S. Collins, May 15, 2018 -
Essential malaria parasite genes revealed
NIAID/NIH news, May 3, 2018 -
Newly described human antibody prevents malaria in mice
NIAID/NIH news, March 19, 2018 -
NIH study identifies new targets for anti-malaria drugs
NICHD/NIH news, October 26, 2017 -
NIH funds seven International Centers of Excellence for Malaria Research that work in 14 countries in Africa, Asia and Latin America
NIAID/NIH news, April 21, 2017 -
NIH begins study of vaccine to protect against mosquito-borne diseases
NIAID/NIH news, February 21, 2017 -
Experimental PfSPZ malaria vaccine provides durable protection against multiple strains in NIH clinical trial
NIAID/NIH news, February 21, 2017 -
Investigational PfSPZ malaria vaccine demonstrates considerable protection in Malian adults for duration of malaria season
NIAID/NIH news, February 16, 2017 -
Raising the curtain on cerebral malaria's deadly agents
NINDS/NIH news, December 6, 2016 -
Investigational malaria vaccine protects healthy U.S. adults for more than one year
NIAID/NIH news, May 9, 2016 -
Testing curbs malaria drug misuse in Kenya
Jan / Feb 2016
Global Health Matters
Related Fogarty News and Information
NIH News and Resources
- National Institute of Allergy and Infectious Diseases (NIAID) Malaria Topic Page
- National Library of Medicine (NLM)'s MedlinePlus on Malaria
Other US Government Resources
Other Online Resources